Why EPA's ‘forever chemicals’ proposal will stir controversy; in post-Roe California, a painful wait to end a wanted pregnancy

EPA's set to propose new national drinking water standards for two of the most studied pollutants among the thousands of "forever chemicals." ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Why EPA's long-awaited proposal on two 'forever chemicals' is bound to be controversial By Brittany Trang Hyacinth Empinado/STAT EPA's set to propose new national drinking water standards for two of the most studied pollutants among the thousands of "forever chemicals." Read More Every kick, a reminder: in post-Roe California, a painful wait before ending a wanted pregnancy By Eric Boodman Constanza Hevia for STAT She needed an abortion in California after the Dobbs decision. But with a surge of out-of-state patients, the wait was too long to bear. Read More STAT+: Medicare's home hospital program may soon get a lifeline from Congress. Can it prove its worth? By Mario Aguilar Adobe Medicare's hospital at home program may soon be extended. It will need to prove it can deliver good outcomes and be financially viable. Read More Sponsored Insight by Organon This is the decade of biosimilar market growth As inflation continues to climb, it's more critical than ever to help reduce costs on the health care system and increase competition in biologic medicines. With so many biologic medications expected to come off patent, additional biosimilar medications may be developed. This new era of biosimilar competition may improve medication access. Read more about a future with biosimilars. Infectious disease board recommends hospitals stop screening asymptomatic patients for Covid-19 By Jason Mast Adobe An influential board of infectious disease experts recommends that hospitals stop routine Covid-19 screenings, which can lead to ER delays. Read More STAT+: California wants to revoke a CVS mail-order license for illegally filling opioid and ADHD prescriptions By Ed Silverman Gene J. Puskar/AP CVS ignored red flags that were signs that “numerous controlled substances… were not issued for a legitimate medical purpose.” Read More In a first, children with rare genetic diseases get mitochondrial transplants from their mothers By Megan Molteni Adobe The new procedure involved augmenting children's blood-forming stem cells with healthy mitochondria donated by their mothers. Read More Opinion: Specialized centers can help realign the U.S.'s moral compass for sickle cell disease By Amar Kelkar and Julie Kanter and Payal Desai Michael Conroy/AP Creating comprehensive care centers for people with sickle cell disease is needed to address this long-overlooked life-threatening condition. Read More STAT+: Young private equity firm Catalio to absorb hedge fund HealthCor, capping off busy year of investment M&A By Allison DeAngelis Adobe Two veterans of the health care investing world are planning to step back and sell their hedge fund to the fast-growing firm Catalio. Read More Wednesday, December 21, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser